Year 2019 / Volume 111 / Number 10
Case Report
Regression of a giant pseudopolyp in a patient with colonic Crohn’s disease after therapy with infliximab

801-803

DOI: 10.17235/reed.2019.6252/2019

José Francisco Sánchez Melgarejo, Belén Navarro, José María Rubio, Guillermo Bastida, Pilar Nos,

Abstract
Giant inflammatory pseudopolyps (> 15 mm) are an uncommon complication of inflammatory bowel disease (IBD) and a differential diagnosis with adenomas and carcinomas is challenging. Although usually asymptomatic, they may result in intestinal obstruction or intussusception due to their size. The standard management involves lesion biopsies and endoscopic excision for selected cases; surgery is usually reserved for size-associated complications or an uncertain pathology. We report the case of a 43-year-old female patient with Crohn’s disease (CD) in clinical remission, with no specific treatment at the time. A giant pseudopolyp of 40-mm was found during a screening colonoscopy. Therapy was initiated with infliximab and azathioprine in an attempt to reduce the size of the polyp and allow an endoscopic resection. Additional colonoscopies were performed following induction doses at weeks 0, 2, and 6, which revealed a reduced lesion size. Mucosal resection was attempted but failed due to severe fibrosis, which prevented base injections from lifting up the polyp. However, a follow-up colonoscopy three months later showed that the lesion had completely disappeared. The evidence in the literature regarding giant pseudopolyp management is scarce, but reports indicate that they rarely disappear with medical therapy alone and usually require surgery or endoscopic resection.
Share Button
New comment
Comments
No comments for this article
References
1. Wyse J, Lamoureux E, Gordon PH, Bitton A. Occult Dysplasia in a Localized Giant Pseudopolyp in Crohn’s Colitis: A Case Report. Can J Gastroenterol. 2009;23(7):477–8.
2. Choi YS, Suh JP, Lee IT, Kim JK, Lee SH, Cho KR, et al. Regression of giant pseudopolyps in inflammatory bowel disease. J Crohn’s Colitis. Oxford University Press; 2012 Mar 1;6(2):240–3.
3. Sheikholeslami M-R, Schaefer RF, Mukunyadzi P. Diffuse Giant Inflammatory Polyposis A Challenging Clinicopathologic Diagnosis. Arch Pathol Lab Med. 2004;128:1286–8.
4. Arévalo F, Aguilar R, Ramos C, Arias J, Castillo S, Monge E. [Inflamatory polyps of the colon an evaluation]. Rev Gastroenterol Peru. 29(1):40–3.
5. Maggs JRL, Browning LC, Warren BF, Travis SPL. Obstructing giant post-inflammatory polyposis in ulcerative colitis: Case report and review of the literature. J Crohn’s Colitis. Oxford University Press; 2008 Jun 1;2(2):170–80.
6. Syal G, Budhraja V. Recurrent Obstructive Giant Inflammatory Polyposis of the Colon. ACG case reports J. American College of Gastroenterology; 2016 Aug;3(4):e89.
7. Abou Rached A, Saba J, El Masri L, Nakhoul M, Razzouk C. Obstructive Giant Inflammatory Polyposis: Is It Related to the Severity or the Duration of the Inflammatory Bowel Disease? Two Case Reports. Case Rep Gastrointest Med. Hindawi Limited; 2018;2018:3251549.
8. Munchar J, Rahman HA, Zawawi MM. Localized giant pseudopolyposis in ulcerative colitis. Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1385–7.
9. Liatsos C, Kyriakos N, Panagou E, Karagiannis S, Salemis N, Mavrogiannis C. Inflammatory polypoid mass treated with Infliximab in a Crohn’s disease patient. J Crohn’s Colitis. Oxford University Press; 2010 Dec 1;4(6):707–8.
10. Pilichos C, Preza A, Demonakou M, Kapatsoris D, Bouras C. Topical budesonide for treating giant rectal pseudopolyposis. Anticancer Res. 25(4):2961–4.
Related articles

Letter

Coincidental oral lesions in Crohn’s disease

DOI: 10.17235/reed.2023.9992/2023

Letter

Duodenal stenosis surgical treatment in Crohn’s disease

DOI: 10.17235/reed.2023.9521/2023

Digestive Diseases Image

Peristomal cutaneous Crohn's disease by contiguity

DOI: 10.17235/reed.2022.8909/2022

Letter

Anal neoplasia and perianal Crohn’s disease: myth or reality?

DOI: 10.17235/reed.2021.8317/2021

Letter

Crohn’s disease in patients treated with etanercept

DOI: 10.17235/reed.2019.6554/2019

Original

Megacolon in inflammatory bowel disease: response to infliximab

DOI: 10.17235/reed.2020.6394/2019

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Letter to the Editor

Adnexal localization of Crohn’s disease and recurrent massive ovary cysts

DOI: 10.17235/reed.2016.4301/2016

Case Report

Metastatic Crohn’s disease in pediatrics

DOI: 10.17235/reed.2016.3948/2015

Letter to the Editor

Crohn’s disease and Sweet’s syndrome: A debut together

DOI: 10.17235/reed.2015.3842/2015

Case Report

Ovarian involvement in Crohn´s disease: A rare complication

DOI: 10.17235/reed.2015.3764/2015

Citation tools
Sánchez Melgarejo J, Navarro B, Rubio J, Bastida G, Nos P. Regression of a giant pseudopolyp in a patient with colonic Crohn’s disease after therapy with infliximab . 6252/2019


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1083 visits.
This article has been downloaded 206 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 25/02/2019

Accepted: 06/05/2019

Online First: 29/07/2019

Published: 03/10/2019

Article Online First time: 154 days

Article editing time: 220 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology